{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:31:13Z","timestamp":1791045073625,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82405072"],"award-info":[{"award-number":["82405072"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304927"],"award-info":[{"award-number":["82304927"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274286"],"award-info":[{"award-number":["82274286"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Joint Funds of Basic and Applied Basic Research Fund of Guangdong","award":["2023A1515110041"],"award-info":[{"award-number":["2023A1515110041"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M741596"],"award-info":[{"award-number":["2023M741596"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Hepatocellular carcinoma (HCC) mainly develops in cases of fibrosis and cirrhosis and is accompanied by intestinal flora disorder. HCC also affects CD8<jats:sup>+<\/jats:sup> T cell immune function. 5,7-Dimethoxyflavone (DMF), an active flavonoid with anti-tumor effect, is found in <jats:italic>Kaempferia parviflora<\/jats:italic>. However, whether DMF can treat HCC remains unclear. This study aims to investigate the effect of DMF on HCC and to explore its possible mechanism, focusing on the gut microbiota regulation and the effect of CD8<jats:sup>+<\/jats:sup> T cells in a murine model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The HCC mouse model was induced with diethylnitrosamine\/carbon tetrachloride and orally administered DMF. DMF effects on HCC progression were assessed using hematoxylin and eosin staining, immunohistochemistry, and serum biochemical marker levels. The causal relationship between gut microbes and HCC was explored using 16S rRNA genome-derived taxonomic profiling, microbial transplantation, fecal high-throughput targeted metabolomics, and untargeted serum metabolomic analyses. Transcriptome analysis, molecular docking, quantitative real-time polymerase chain reaction, and Western blot were applied to study the genes targeted by DMF. CD8<jats:sup>+<\/jats:sup> T cell infiltration and tumor-killing factors were studied using flow cytometry and immunofluorescence staining.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>DMF reduced the number of tumors, the largest tumor size, and the liver-to-body ratio while also improving liver function. An antibiotic cocktail lowered the anti-tumor effect of DMF, indicating that DMF inhibition of HCC is partially dependent on the gut microbiota. DMF considerably upregulates <jats:italic>Akkermansia muciniphila<\/jats:italic> during chemical hepatocarcinogenesis in mice. DMF-upregulated <jats:italic>A. muciniphila<\/jats:italic> leading to intestinal barrier repair, which inhibited HCC progression by enhancing antioxidant capacity through glutathione regulation and 11,12-DIHETrE down-regulation. An untargeted serum metabolomic analysis showed that there existed additional mechanisms underlying DMF anti-tumor effect following its absorption into the bloodstream. DMF enhances the infiltration effect of CD8<jats:sup>+<\/jats:sup> T cells and upregulates interferon-gamma expression in HCC tissue. Overall, 822 genes, including chemokine (C\u2013C motif) ligand 2 (CCL2), were significantly downregulated by DMF treatment in HCC cells. Notably, DMF binds strongly with nuclear factor kappa-B (NF-\u03baB) and inhibits NF-\u03baB p65 phosphorylation, sequentially suppressing the expression of downstream protein CCL2, which mediate the crosstalk between tumor cells and CD8<jats:sup>+<\/jats:sup> T cells.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>DMF improves <jats:italic>A. muciniphila<\/jats:italic>-mediated intestinal barrier repair and inhibits the NF-\u03baB\/CCL2 pathway in HCC cells, enhancing the immunity of CD8<jats:sup>+<\/jats:sup> T cells in the liver. Hence, it may serve as a potential candidate for HCC treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s13020-025-01233-8","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T01:01:59Z","timestamp":1759885319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["5,7-dimethoxyflavone inhibits hepatocellular carcinoma progression via increasing intestinal Akkermansia muciniphila and hepatic CD8+ T cell infiltration"],"prefix":"10.1186","volume":"20","author":[{"given":"Weicong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changshun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengchen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songqi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"issue":"3","key":"1233_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"10360","key":"1233_CR2","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400(10360):1345\u201362.","journal-title":"Lancet"},{"issue":"4","key":"1233_CR3","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.jhep.2021.07.004","volume":"75","author":"J Bruix","year":"2021","unstructured":"Bruix J, Chan SL, Galle PR, Rimassa L, Sangro B. Systemic treatment of hepatocellular carcinoma: an EASL position paper. J Hepatol. 2021;75(4):960\u201374.","journal-title":"J Hepatol"},{"issue":"20","key":"1233_CR4","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","volume":"382","author":"RS Finn","year":"2020","unstructured":"Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, Kim TY, et al. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med. 2020;382(20):1894\u2013905.","journal-title":"N Engl J Med"},{"issue":"2","key":"1233_CR5","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jhep.2019.08.016","volume":"72","author":"RF Schwabe","year":"2020","unstructured":"Schwabe RF, Greten TF. Gut microbiome in HCC-mechanisms, diagnosis and therapy. J Hepatol. 2020;72(2):230\u20138.","journal-title":"J Hepatol"},{"issue":"2","key":"1233_CR6","doi-asserted-by":"publisher","first-page":"2240031","DOI":"10.1080\/19490976.2023.2240031","volume":"15","author":"J Rajapakse","year":"2023","unstructured":"Rajapakse J, Khatiwada S, Akon AC, Yu KL, Shen S, Zekry A. Unveiling the complex relationship between gut microbiota and liver cancer: opportunities for novel therapeutic interventions. Gut Microbes. 2023;15(2):2240031.","journal-title":"Gut Microbes"},{"key":"1233_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cells12050788","author":"K Deka","year":"2023","unstructured":"Deka K, Li Y. Transcriptional regulation during aberrant activation of NF-\u03baB signalling in cancer. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12050788.","journal-title":"Cells"},{"issue":"9","key":"1233_CR8","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41568-021-00383-9","volume":"21","author":"X Li","year":"2021","unstructured":"Li X, Ramadori P, Pfister D, Seehawer M, Zender L, Heikenwalder M. The immunological and metabolic landscape in primary and metastatic liver cancer. Nat Rev Cancer. 2021;21(9):541\u201357.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1233_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jhep.2023.02.036","volume":"79","author":"M Xie","year":"2023","unstructured":"Xie M, Lin Z, Ji X, Luo X, Zhang Z, Sun M, et al. FGF19\/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2. J Hepatol. 2023;79(1):109\u201325.","journal-title":"J Hepatol"},{"key":"1233_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/nu11102396","author":"AI Elshamy","year":"2019","unstructured":"Elshamy AI, Mohamed TA, Essa AF, Abd-Elgawad AM, Alqahtani AS, Shahat AA, et al. Recent advances in Kaempferia phytochemistry and biological activity: a comprehensive review. Nutrients. 2019. https:\/\/doi.org\/10.3390\/nu11102396.","journal-title":"Nutrients"},{"key":"1233_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2022.105029","volume":"92","author":"A Hashiguchi","year":"2022","unstructured":"Hashiguchi A, San Thawtar M, Duangsodsri T, Kusano M, Watanabe KN. Biofunctional properties and plant physiology of Kaempferia spp.: status and trends. J Funct Foods. 2022;92:105029.","journal-title":"J Funct Foods"},{"key":"1233_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1756-8722-4-52","volume":"4","author":"B Wudtiwai","year":"2011","unstructured":"Wudtiwai B, Sripanidkulchai B, Kongtawelert P, Banjerdpongchai R. Methoxyflavone derivatives modulate the effect of TRAIL-induced apoptosis in human leukemic cell lines. J Hematol Oncol. 2011;4:52.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"1233_CR13","first-page":"695","volume":"10","author":"V Leardkamolkarn","year":"2009","unstructured":"Leardkamolkarn V, Tiamyuyen S, Sripanidkulchai BO. Pharmacological activity of Kaempferia parviflora extract against human bile duct cancer cell lines. Asian Pac J Cancer Prev. 2009;10(4):695\u20138.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"9","key":"1233_CR14","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1002\/ptr.6677","volume":"34","author":"W Park","year":"2020","unstructured":"Park W, Park MY, Song G, Lim W. 5,7-dimethoxyflavone induces apoptotic cell death in human endometriosis cell lines by activating the endoplasmic reticulum stress pathway. Phytother Res. 2020;34(9):2275\u201386.","journal-title":"Phytother Res"},{"issue":"12","key":"1233_CR15","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1089\/jmf.2016.3800","volume":"19","author":"Y Song","year":"2016","unstructured":"Song Y, Kim MB, Kim C, Kim J, Hwang JK. 5,7-dimethoxyflavone attenuates obesity by inhibiting adipogenesis in 3T3-L1 adipocytes and high-fat diet-induced obese C57BL\/6J mice. J Med Food. 2016;19(12):1111\u20139.","journal-title":"J Med Food"},{"issue":"3","key":"1233_CR16","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s11418-018-1184-z","volume":"72","author":"W Ochiai","year":"2018","unstructured":"Ochiai W, Kobayashi H, Kitaoka S, Kashiwada M, Koyama Y, Nakaishi S, et al. Effect of the active ingredient of Kaempferia parviflora, 5,7-dimethoxyflavone, on the pharmacokinetics of midazolam. J Nat Med. 2018;72(3):607\u201314.","journal-title":"J Nat Med"},{"key":"1233_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2022.133959","volume":"399","author":"Z Li","year":"2023","unstructured":"Li Z, Ren Z, Zhao L, Chen L, Yu Y, Wang D, et al. Unique roles in health promotion of dietary flavonoids through gut microbiota regulation: current understanding and future perspectives. Food Chem. 2023;399:133959.","journal-title":"Food Chem"},{"issue":"1","key":"1233_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s40168-022-01390-0","volume":"10","author":"J Yan","year":"2022","unstructured":"Yan J, Pan Y, Shao W, Wang C, Wang R, He Y, et al. Beneficial effect of the short-chain fatty acid propionate on vascular calcification through intestinal microbiota remodelling. Microbiome. 2022;10(1):195.","journal-title":"Microbiome"},{"key":"1233_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115825","volume":"301","author":"W Chen","year":"2023","unstructured":"Chen W, Yang X, Sun J, Chen Y, Zhao W, He C, et al. Biejiajian pill inhibits progression of hepatocellular carcinoma by downregulating PDGFR\u03b2 signaling in cancer-associated fibroblasts. J Ethnopharmacol. 2023;301:115825.","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"1233_CR20","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","volume":"21","author":"DH Dapito","year":"2012","unstructured":"Dapito DH, Mencin A, Gwak GY, Pradere JP, Jang MK, Mederacke I, et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell. 2012;21(4):504\u201316.","journal-title":"Cancer Cell"},{"issue":"1","key":"1233_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103654","volume":"25","author":"Y Wang","year":"2022","unstructured":"Wang Y, Tang J, Lv Q, Tan Y, Dong X, Liu H, et al. Establishment and resilience of transplanted gut microbiota in aged mice. iScience. 2022;25(1):103654.","journal-title":"iScience"},{"issue":"8","key":"1233_CR22","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1038\/ismej.2012.8","volume":"6","author":"JG Caporaso","year":"2012","unstructured":"Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Huntley J, Fierer N, et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J. 2012;6(8):1621\u20134.","journal-title":"ISME J"},{"issue":"7","key":"1233_CR23","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/s41592-021-01197-1","volume":"18","author":"S Alseekh","year":"2021","unstructured":"Alseekh S, Aharoni A, Brotman Y, Contrepois K, D\u2019Auria J, Ewald J, et al. Mass spectrometry-based metabolomics: a guide for annotation, quantification and best reporting practices. Nat Methods. 2021;18(7):747\u201356.","journal-title":"Nat Methods"},{"issue":"9","key":"1233_CR24","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41592-018-0110-3","volume":"15","author":"X Domingo-Almenara","year":"2018","unstructured":"Domingo-Almenara X, Montenegro-Burke JR, Ivanisevic J, Thomas A, Sidib\u00e9 J, Teav T, et al. XCMS-MRM and METLIN-MRM: a cloud library and public resource for targeted analysis of small molecules. Nat Methods. 2018;15(9):681\u20134.","journal-title":"Nat Methods"},{"key":"1233_CR25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-seq data with or without a reference genome. BMC Bioinformatics. 2011;12:323.","journal-title":"BMC Bioinformatics"},{"issue":"20","key":"1233_CR26","doi-asserted-by":"publisher","first-page":"8067","DOI":"10.1158\/0008-5472.CAN-09-0901","volume":"69","author":"K Wu","year":"2009","unstructured":"Wu K, Kryczek I, Chen L, Zou W, Welling TH. Kupffer cell suppression of CD8+ T cells in human Hepatocellular Carcinoma is mediated by B7\u2013H1\/Programmed Death-1 interactions. Cancer Res. 2009;69(20):8067\u201375.","journal-title":"Cancer Res"},{"issue":"3","key":"1233_CR27","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1002\/hep.24485","volume":"54","author":"A Mazzocca","year":"2011","unstructured":"Mazzocca A, Dituri F, Lupo L, Quaranta M, Antonaci S, Giannelli G. Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts. Hepatology. 2011;54(3):920\u201330.","journal-title":"Hepatology"},{"issue":"10","key":"1233_CR28","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/s43018-021-00251-3","volume":"2","author":"N Iida","year":"2021","unstructured":"Iida N, Mizukoshi E, Yamashita T, Yutani M, Seishima J, Wang Z, et al. Chronic liver disease enables gut Enterococcus faecalis colonization to promote liver carcinogenesis. Nat Cancer. 2021;2(10):1039\u201354.","journal-title":"Nat Cancer"},{"issue":"1","key":"1233_CR29","doi-asserted-by":"publisher","first-page":"3964","DOI":"10.1038\/s41467-022-31312-5","volume":"13","author":"KM Schneider","year":"2022","unstructured":"Schneider KM, Mohs A, Gui W, Galvez E, Candels LS, Hoenicke L, et al. Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironment. Nat Commun. 2022;13(1):3964.","journal-title":"Nat Commun"},{"issue":"1","key":"1233_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1927633","volume":"13","author":"Y Rao","year":"2021","unstructured":"Rao Y, Kuang Z, Li C, Guo S, Xu Y, Zhao D, et al. Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis. Gut Microbes. 2021;13(1):1\u201319.","journal-title":"Gut Microbes"},{"issue":"1","key":"1233_CR31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.apsb.2024.10.010","volume":"15","author":"A Zhuge","year":"2025","unstructured":"Zhuge A, Li S, Han S, Yuan Y, Shen J, Wu W, et al. Akkermansia muciniphila-derived acetate activates the hepatic AMPK\/SIRT1\/PGC-1\u03b1 axis to alleviate ferroptosis in metabolic-associated fatty liver disease. Acta Pharm Sin B. 2025;15(1):151\u201367.","journal-title":"Acta Pharm Sin B"},{"issue":"3","key":"1233_CR32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","volume":"19","author":"JM Llovet","year":"2022","unstructured":"Llovet JM, Castet F, Heikenwalder M, Maini MK, Mazzaferro V, Pinato DJ, et al. Immunotherapies for hepatocellular carcinoma. Nat Rev Clin Oncol. 2022;19(3):151\u201372.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"1233_CR33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","volume":"6","author":"H Zhao","year":"2021","unstructured":"Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y, et al. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther. 2021;6(1):263.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"1233_CR34","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.dld.2010.10.015","volume":"43","author":"C Cesaro","year":"2011","unstructured":"Cesaro C, Tiso A, Del PA, Cariello R, Tuccillo C, Cotticelli G, et al. Gut microbiota and probiotics in chronic liver diseases. Dig Liver Dis. 2011;43(6):431\u20138.","journal-title":"Dig Liver Dis"},{"issue":"17","key":"1233_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13174342","volume":"13","author":"J Giraud","year":"2021","unstructured":"Giraud J, Saleh M. Host\u2013microbiota interactions in liver inflammation and cancer. Cancers (Basel). 2021;13(17):4342.","journal-title":"Cancers (Basel)"},{"key":"1233_CR36","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.tifs.2019.09.005","volume":"93","author":"V Gowd","year":"2019","unstructured":"Gowd V, Karim N, Shishir MRI, Xie L, Chen W. Dietary polyphenols to combat the metabolic diseases via altering gut microbiota. Trends Food Sci Technol. 2019;93:81\u201393.","journal-title":"Trends Food Sci Technol"},{"issue":"10","key":"1233_CR37","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41575-022-00631-9","volume":"19","author":"PD Cani","year":"2022","unstructured":"Cani PD, Depommier C, Derrien M, Everard A, de Vos WM. Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms. Nat Rev Gastroenterol Hepatol. 2022;19(10):625\u201337.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1233_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13121461","author":"L Cesarini","year":"2024","unstructured":"Cesarini L, Grignaffini F, Alisi A, Pastore A. Alterations in glutathione redox homeostasis in metabolic dysfunction-associated fatty liver disease: a systematic review. Antioxidants (Basel). 2024. https:\/\/doi.org\/10.3390\/antiox13121461.","journal-title":"Antioxidants (Basel)"},{"issue":"1","key":"1233_CR39","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1194\/jlr.P055640","volume":"56","author":"R Loomba","year":"2015","unstructured":"Loomba R, Quehenberger O, Armando A, Dennis EA. Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis. J Lipid Res. 2015;56(1):185\u201392.","journal-title":"J Lipid Res"},{"issue":"4","key":"1233_CR40","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.jhep.2020.03.046","volume":"73","author":"C L\u00f3pez-Vicario","year":"2020","unstructured":"L\u00f3pez-Vicario C, Checa A, Urdangarin A, Aguilar F, Alcaraz-Quiles J, Caraceni P, et al. Targeted lipidomics reveals extensive changes in circulating lipid mediators in patients with acutely decompensated cirrhosis. J Hepatol. 2020;73(4):817\u201328.","journal-title":"J Hepatol"},{"issue":"7921","key":"1233_CR41","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41586-022-04985-7","volume":"608","author":"M Bae","year":"2022","unstructured":"Bae M, Cassilly CD, Liu X, Park SM, Tusi BK, Chen X, et al. Akkermansia muciniphila phospholipid induces homeostatic immune responses. Nature. 2022;608(7921):168\u201373.","journal-title":"Nature"},{"issue":"1","key":"1233_CR42","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nm.4236","volume":"23","author":"H Plovier","year":"2017","unstructured":"Plovier H, Everard A, Druart C, Depommier C, Van Hul M, Geurts L, et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med. 2017;23(1):107\u201313.","journal-title":"Nat Med"},{"key":"1233_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.216043","volume":"559","author":"Q Wang","year":"2023","unstructured":"Wang Q, Qin Y, Li B. CD8+ T cell exhaustion and cancer immunotherapy. Cancer Lett. 2023;559:216043.","journal-title":"Cancer Lett"},{"issue":"1","key":"1233_CR44","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12943-024-02049-0","volume":"23","author":"B Tang","year":"2024","unstructured":"Tang B, Zhu J, Shi Y, Wang Y, Zhang X, Chen B, et al. Tumor cell-intrinsic MELK enhanced CCL2-dependent immunosuppression to exacerbate hepatocarcinogenesis and confer resistance of HCC to radiotherapy. Mol Cancer. 2024;23(1):137.","journal-title":"Mol Cancer"},{"issue":"45","key":"1233_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202404756","volume":"11","author":"Y Du","year":"2024","unstructured":"Du Y, Wu S, Xi S, Xu W, Sun L, Yan J, et al. ASH1L in hepatoma cells and hepatic stellate cells promotes fibrosis-associated hepatocellular carcinoma by modulating tumor-associated macrophages. Adv Sci. 2024;11(45):e2404756.","journal-title":"Adv Sci"},{"key":"1233_CR46","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009993","author":"X Wei","year":"2025","unstructured":"Wei X, Wang H, Liu H, Wang J, Zhou P, Li X, et al. Disruption of tumor-intrinsic PGAM5 increases anti-PD-1 efficacy through the CCL2 signaling pathway. J Immunother Cancer. 2025. https:\/\/doi.org\/10.1136\/jitc-2024-009993.","journal-title":"J Immunother Cancer"},{"issue":"2","key":"1233_CR47","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrgastro.2010.213","volume":"8","author":"T Luedde","year":"2011","unstructured":"Luedde T, Schwabe RF. NF-\u03baB in the liver-linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2011;8(2):108\u201318.","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01233-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-025-01233-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01233-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T01:02:01Z","timestamp":1759885321000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmjournal.biomedcentral.com\/articles\/10.1186\/s13020-025-01233-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1233"],"URL":"https:\/\/doi.org\/10.1186\/s13020-025-01233-8","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"8 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In this study, all animal procedures were performed following the guidelines of the Animal Ethics Committee of Southern Medical University (approval no: SMUL2020131).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"170"}}